Cresco Labs (CRLBF) Free Cash Flow (2019 - 2026)
Cresco Labs (CRLBF) reported Free Cash Flow of $7.6 million for Q1 2026, up 31.28% on a YoY basis from $5.8 million in Q1 2025, and up 529.68% quarter-over-quarter from $1.2 million in Q4 2025.
Cresco Labs (CRLBF) Free Cash Flow (2019 - 2026) Analysis & Trends
Cresco Labs has reported Free Cash Flow for 8 years, with the latest figure at $7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 31.28% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $35.3 million (down 58.45% YoY), and the FY2025 full-year result was $72.8 million, down 44.85% from the prior year.
- Free Cash Flow for Q1 2026 stood at $7.6 million, up from $1.2 million in the prior quarter.
- The five-year high for Free Cash Flow was $55.4 million in Q3 2024, with the low at -$149.3 million in Q4 2022.
- Historically, Free Cash Flow has averaged $2.8 million across 5 years, with a median of $12.7 million in 2024.
- Annual changes were most pronounced in 2023 — Free Cash Flow plunged 104.65% — and 2025, when it soared 800.96%.
- Cresco Labs' Free Cash Flow stood at -$149.3 million in 2022, then climbed by 26.82% to -$109.3 million in 2023, then jumped by 111.63% to $12.7 million in 2024, then slumped by 90.45% to $1.2 million in 2025, then surged by 529.68% to $7.6 million in 2026.
- The last three Free Cash Flow figures came in at $7.6 million (Q1 2026), $1.2 million (Q4 2025), and $13.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 123.09 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 80.53 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64 Mn |
| Mar 31, 2026 | 7.64 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Mar 31, 2024 | -830,000.00 |
| Mar 31, 2024 | -830,000.00 |
| Dec 31, 2023 | -109.25 Mn |
| Dec 31, 2023 | -109.25 Mn |